The Recall Desk
CriticalFDA (Drugs)·D-0978-2015·Announced 2015-05-13

Detox Transforms Recalls iNDiGO Capsules Containing Undeclared Phenolphthalein

Detox Transforms is recalling iNDiGO capsules because they contain undeclared phenolphthalein, making the product an unapproved drug.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.

Plain-English summary

Detox Transforms is recalling 175 bottles of iNDiGO capsules, 220 mg, 60-count. The product was developed by Signature and is identified by Lot 000034 and expiration date 04/10/17.

The recall was initiated because the product was found to contain undeclared phenolphthalein. This finding means the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), classifying it as an unapproved drug.

The affected units were distributed nationwide. Consumers who have this product should stop using it and contact the recalling firm for further instructions.

The recalled product

Product
iNDiGO capsules, 220 mg, 60-count bottle, Developed by Signature, 1027 Highway 70 W, Suite 227, Garner, NC 27529, UPC 8 52175 00404 4.
Manufacturer
Detox Transforms
Affected units
175

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: 000034
  • Exp 04/10/17

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 5 recalled by Detox Transforms under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →

Same manufacturer · Detox Transforms

See all →